Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-24-100769

Director bought 1,600,000 shares at $18.75 ($30,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2024-09-13 Purchase +1,600,000 $18.75 $30,000,000 3,445,813 I
Open-market purchases · 1,600,000 sh · avg $18.75 · $30,000,000
Loading xslF345X05/tm2424272-1_4seq1.xml…